Showing results (1181-1190 of 1,196) with videos related to
Sort By:
Pageof 120
Bioorganic & Medicinal Chemistry Letters|June 9, 2023
Discovery of novel pyridinones as MGAT2 inhibitors for the treatment of metabolic disordersFang Moore, Wei Wang, Guohua Zhao, et al.Respiratory Research|December 3, 2022
The Establishment of China Bronchiectasis Registry and Research Collaboration (BE-China): Protocol of a prospective multicenter observational studyYong-Hua Gao, Hai-Wen Lu, Bei Mao, et al.Scientific Reports|January 23, 2021
Discovery of a new class of integrin antibodies for fibrosisJi Zhang, Tao Wang, Ashmita Saigal, et al.Chinese Journal of Integrative Medicine|June 20, 2022
Analysis of Chinese Medical Syndrome Features of Ischemic Stroke Based on Similarity of Symptoms SubgroupXiao-Qing Liu, Run-Shun Zhang, Xue-Zhong Zhou, et al.Bioorganic & Medicinal Chemistry Letters|March 24, 2025
Discovery of liver-selective glucokinase activators comprising N-(4-alkylthiazol-2-yl)benzamides and N-(3-alkyl-1,2,4-thiadiazol-5-yl)benzamides for the treatment of metabolic disordersDavid S Yoon, Shung Wu, Sean S Chen, et al.Gynecologic Oncology|January 29, 2019
53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancerRachel M Hurley, Andrea E Wahner Hendrickson, Daniel W Visscher, et al.Frontiers in Cardiovascular Medicine|April 4, 2022
Patients With Bicuspid Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-AnalysisYi Zhang, Tian-Yuan Xiong, Yi-Ming Li, et al.Journal of Medicinal Chemistry|February 12, 2008
Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetesWei Meng, Bruce A Ellsworth, Alexandra A Nirschl, et al.JACC. Cardiovascular Interventions|August 18, 2022
Sex Difference in Outcomes Following Transcatheter Aortic Valve Replacement in Bicuspid Aortic StenosisJing-Jing He, Tian-Yuan Xiong, Yi-Jun Yao, et al.Journal of Medicinal Chemistry|September 19, 2023
Discovery of <b>12</b> (BMS-986172) as a Highly Potent MGAT2 Inhibitor that Achieved Targeted Efficacious Exposures at a Low Human Dose for the Treatment of Metabolic DisordersWei Meng, Robert Brigance, James Mignone, et al.Pageof 120